InvestorsHub Logo
Post# of 4973771
Next 10
Followers 971
Posts 383037
Boards Moderated 6
Alias Born 06/24/2011

Re: None

Thursday, 12/21/2023 3:39:01 PM

Thursday, December 21, 2023 3:39:01 PM

Post# of 4973771
$RNXT The pivotal Phase III CouGar study will be the second clinical trial evaluating RenovoGem™, a combination drug-device product, in a difficult-to-access solid tumor cancer. Learn more: https://bit.ly/4asSZjH

$RNXT #BileDuctCancer

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.